CorMedix Inc (NASDAQ: CRMD) stock enjoyed a major increase of 11.2% on 9/10/24. The shares closed at $6.23. Moreover, trading volume in this advance was exceptionally high at 233% of normal. The stock has been exceptionally strong relative to the market over the last nine months but is unchanged during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, CRMD is expected to continue to be Value Creation neutral.
CorMedix has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. CorMedix has a very low Appreciation Score of 4 but a very high Power Rating of 95, with the Neutral Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment